ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

VYNE Company Profile and Key Details

NASDAQ : VYNE

VYNE Therapeutics Inc.

$2.19

-0.14-6.01%

At Close 4:00 PM

$2.31

0.12+5.48%

After-Market 03:02 PM

58.55

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

VYNE Stock Price Chart

Stock Price Today

VYNE Therapeutics Inc. (VYNE) stock declined over -6.01%, trading at $2.19 on NASDAQ, down from the previous close of $2.33. The stock opened at $2.27, fluctuating between $2.16 and $2.26 in the recent session.

Stock Snapshot

2.33

Prev. Close

2.27

Open

33.31M

Market Cap

15.21M

Number of Shares

2.16

Day Low

2.26

Day High

-2.35

P/E Ratio

82.98%

Free Float in %

-0.93

EPS (TTM)

2.86

Book Value

-0.82

Cash Flow per Share

44.75K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 07, 2025	2.27	2.35	2.16	2.19	44.78K
Mar 06, 2025	2.36	2.39	2.25	2.33	9.09K
Mar 05, 2025	2.32	2.57	2.22	2.39	38.74K
Mar 04, 2025	2.36	2.50	2.31	2.31	37.09K
Mar 03, 2025	2.52	2.60	2.23	2.35	116.11K
Feb 28, 2025	2.25	2.56	2.25	2.52	33.6K
Feb 27, 2025	2.50	2.57	2.46	2.50	27.33K
Feb 26, 2025	2.60	2.75	2.47	2.55	64.9K
Feb 25, 2025	2.83	2.83	2.59	2.65	49.51K
Feb 24, 2025	2.76	2.86	2.67	2.80	68.45K
Feb 21, 2025	2.75	2.94	2.62	2.74	67.72K
Feb 20, 2025	2.57	2.77	2.50	2.70	151.77K
Feb 19, 2025	2.55	2.62	2.44	2.52	28.97K
Feb 18, 2025	2.46	2.56	2.39	2.50	50.18K
Feb 14, 2025	2.48	2.65	2.45	2.47	110.3K
Feb 13, 2025	2.54	2.54	2.36	2.49	83.07K
Feb 12, 2025	2.41	2.56	2.35	2.51	42.3K
Feb 11, 2025	2.40	2.50	2.26	2.47	68.5K
Feb 10, 2025	2.33	2.44	2.26	2.40	97.16K
Feb 07, 2025	2.43	2.49	2.34	2.41	64.94K

Contact Details

Bridgewater, NJ 08807

United States

Website: https://www.vynetherapeutics.comContact: 800 775 7936

About Company

VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is also developing VYN201, a bromodomain and extra-terminal (BET) inhibitor for various immuno-inflammatory diseases, including skin diseases; and VYN202, BET inhibitor compounds that are selective for bromodomain 2. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.

Frequently Asked Questions

What is the current VYNE Therapeutics Inc. (VYNE) stock price?

VYNE Therapeutics Inc. (NASDAQ: VYNE) stock price is $2.19 in the last trading session. During the trading session, VYNE stock reached the peak price of $2.26 while $2.16 was the lowest point it dropped to. The percentage change in VYNE stock occurred in the recent session was -6.01% while the dollar amount for the price change in VYNE stock was -$0.14.

VYNE's industry and sector of operation?

The NASDAQ listed VYNE is part of Biotechnology industry that operates in the broader Healthcare sector. VYNE Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VYNE?

Dr. Iain A. Stuart Ph.D.
Chief Scientific Officer
Mr. David Schuz
Senior Vice President of Intellectual Property
Mr. Tyler Zeronda
Chief Financial Officer & Treasurer
Dr. Darrell S. Rigel M.S., M.D., MS
Consultant
Ms. Mutya Harsch J.D.
Gen. Counsel, Chief Legal Officer & Company Sec.
Dr. Russell Elliott D.Phil.
Senior Vice President of Pharmaceutical Devel.
Mr. David T. Domzalski
Chief Executive Officer, Pres & Director

How VYNE did perform over past 52-week?

VYNE's closing price is 39.49% higher than its 52-week low of $1.57 where as its distance from 52-week high of $4.30 is -49.07%.

How many employees does VYNE have?

Number of VYNE employees currently stands at 10.

Link for VYNE official website?

Official Website of VYNE is: https://www.vynetherapeutics.com

How do I contact VYNE?

VYNE could be contacted at phone 800 775 7936 and can also be accessed through its website. VYNE operates from 520 U.S. Highway 22, Bridgewater, NJ 08807, United States.

How many shares of VYNE are traded daily?

VYNE stock volume for the day was 44.75K shares. The average number of VYNE shares traded daily for last 3 months was 103.69K.

What is the market cap of VYNE currently?

The market value of VYNE currently stands at $33.31M with its latest stock price at $2.19 and 15.21M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	10
Beta	1.25
Sales or Revenue	$424.00K
5Y Sales Change%	-0.999%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology